3M maintained its full-year earnings expectation of $7.30 to $7.55 per share, with organic local-currency sales growth of 3% to 6% (about $31.8 billion to $32.72 billion, based on 2013 revenues of $30.87 billion). Foreign currency is expected to reduce sales by approximately 1% for the year, versus a previous expectation of neutral to minus 1%.
The consensus estimates for the second quarter call for EPS of $1.91 on revenues of $8.13 billion. Analysts’ consensus full-year estimates call for EPS of $7.46 on revenues of $32.35 billion.
The company’s CEO said:
Our teams delivered positive organic growth in all business groups and geographic areas, we posted strong margins across the portfolio and we returned a record amount of cash to shareholders. At the same time we increased investments in R&D and commercialization to help secure future growth in the business.
3M’s sales in the quarter grew the most in its health care division, rising 4.8% to $1.4 billion. The industrial division grew revenue 3.1% to $2.8 billion, and the safety and graphics division sales rose 1.7% to $1.4 billion. The consumer division’s sales dropped 0.2% to $1.1 billion, with stationery and office supplies leading the decline.
The slight miss on EPS and the shortfall in revenues likely will weigh on 3M’s share price.
Shares were down about 2.4% in premarket trading Thursday, at $135.63. The current 52-week range is $102.89 to $140.43. Thomson Reuters had a consensus analyst price target of around $141.20 before the report.
Top Gaining Stocks
Top Losing Stocks